Top Story

Stress testing after PCI varies across VA hospitals

August 3, 2015

Of more than 10,000 patients who underwent PCI at Veterans Affairs hospitals, only 22% had a stress test within 1 year and 38% within 2 years, researchers reported in a new study.

“Stress testing after PCI in fee-for-service settings is common and rates vary by hospital. Rates of stress testing after PCI within integrated health care systems, such as the VA, are unknown,” Steven M. Bradley, MD, MPH, from the VA Eastern Colorado Health Care System in Denver and a Cardiology Today’s Intervention Editorial Board member, and colleagues wrote.


BLOG: Patient financing also can be used as a marketing tool

August 3, 2015
I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine whether they should…

Enrollment begins for two trials of dabigatran

August 2, 2015
The first U.S. patients have been enrolled in the RE-DUAL PCI and RE-CIRCUIT trials of the safety and efficacy of dabigatran in patients with nonvalvular atrial…

Trial assessing drug-coated balloon for PAD underway

August 1, 2015
The Spectranetics Corporation announced that enrollment is completed for the ILLUMNENATE Pivotal trial, which is evaluating the use of a drug-coated angioplasty balloon…
In the Journals

ADVICE: Adenosine-guided pulmonary vein isolation during AF ablation safe, effective

July 31, 2015
When adenosine testing was used to identify dormant pulmonary vein conduction in patients with atrial fibrillation undergoing catheter ablation, the rate of…
More News Headlines »
Highlights from Lipid Forum 2015™: Focus on Hypertriglyceridemia

Highlights from Lipid Forum 2015®: Focus on Hypertriglyceridemia

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent yet modifiable risk factor for atherosclerotic disease, pancreatitis, and…
More »
VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

July 17, 2015
PHILADELPHIA — In this video, Joseph Rossano, MD, MS, FAAP, FAAC, medical director of HF/transplantation at…
More »
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »